Imagine the heart-wrenching moment a parent questions every decision they made during pregnancy, fearing it might have contributed to their child’s autism. This was the reality for countless families last September when former U.S. President Donald Trump publicly linked Tylenol use during pregnancy to a ‘very increased risk of autism.’ But here’s where it gets controversial: despite the emotional turmoil this claim caused, a groundbreaking study published in The Lancet Obstetrics, Gynaecology & Women’s Health has decisively refuted this assertion, leaving many to wonder why such unsubstantiated claims gain traction in the first place.
Allison Chang, a mother whose eldest son has autism and ADHD, knows this struggle all too well. As part of a research network investigating neurodevelopmental disorders and a PhD candidate at the University of Toronto, she’s spent years unraveling the complex interplay of genetics and environment behind these conditions. Yet, Trump’s remarks sent her spiraling into self-doubt. ‘Oh my gosh, did I take Tylenol? What did I do wrong as a parent?’ she recalls. Her experience highlights the profound anxiety such statements can trigger, even among those who understand the science.
And this is the part most people miss: the Lancet study wasn’t just another review—it was a robust meta-analysis, the gold standard in research, which adjusted for genetic risks, something earlier studies overlooked. Led by an international team of scientists from Italy, Sweden, Norway, and the UK, it found no evidence linking acetaminophen (Tylenol’s active ingredient) to autism, ADHD, or intellectual disabilities. This aligns with a November study in the British Medical Journal, which also dismissed the claim.
Experts like Evdokia Anagnostou, co-lead of the Autism Research Center at Holland Bloorview Kids Rehabilitation Hospital, emphasize the study’s rigor. ‘Its findings are consistent with what we already knew,’ adds Stephen Scherer, a leading autism geneticist at the Hospital for Sick Children in Toronto. ‘They contradict what RFK Jr. and President Trump told us from the White House.’
Yet, the damage was already done. Medical professionals like Tali Bogler at St. Michael’s Hospital in Toronto report a ‘clear increase in concern and hesitancy’ among pregnant women about taking acetaminophen. While some, like Eda Karacabeyli at the University of British Columbia, note patients are simply asking more questions about medication safety, the ripple effects are undeniable. Here’s the bold question: Are we prioritizing unfounded fears over proven science, and at what cost?
Dr. Scherer warns of the ‘opportunity cost’ of diverting attention to debunked claims. He recalls the aftermath of Andrew Wakefield’s fraudulent 1998 MMR vaccine study, which stalled critical research for years. ‘Every time we revisit these debunked claims, it takes time away from exploring real causes and solutions,’ he explains.
In Canada, researchers like Dr. Anagnostou are now grappling with how to address these fears. ‘Anxieties have changed,’ she says. ‘This wasn’t a priority for families before, but now it’s all they want answers to.’ Her inbox flooded with distressed emails from mothers questioning their past decisions, a stark reminder of the harm caused by misinformation.
So, here’s the provocative thought: In an era of misinformation, how do we hold leaders accountable for spreading fear over facts? And more importantly, how do we ensure parents like Allison Chang can trust the science without second-guessing themselves? Let’s discuss—what do you think?
